Stride
LRN NYSE Education Services Financials FY2017βFY2026
Stride's revenue rose 4.7% to $2.5 billion in fiscal 2026. Its operating margin was 17.9%, up from 15.0% a year earlier. Free cash flow was $433 million, up 0.5%. It paid out $189 million in dividends and buybacks, 44% of free cash flow. The diluted share count fell 2.2%.
What Stride does
No business description yet.
- Legal name
- Stride, Inc.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001104659-26-090515
0001157408
Revenue and margins
Stride had $2.5B of revenue in fiscal 2026, up 4.7% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 107.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $433M in fiscal 2026, 17.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Stride returned $189M to shareholders in fiscal 2026, 44% of free cash flow. The diluted share count fell 2.2%.
Value Stride yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $423M and divides by 47.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 11.0x Β· peers 18.0x Β· sector 17.9x.
Balance sheet
Cash, debt and the ratios that show how comfortably Stride can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $389M | $523M | $692M | $985M | $958M |
| Debt incl. finance leases | $478M | $470M | $470M | $503M | $535M |
| Net debt / EBITDA | 0.4x | β0.2x | β0.6x | β1.0x | β0.7x |
| Debt / equity | 0.6x | 0.5x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 23.6x | 23.8x | 33.2x | 39.4x | 43.2x |
| Current ratio | 3.2x | 3.5x | 5.1x | 5.4x | 5.9x |
| Quick ratio | 3.0x | 3.3x | 5.0x | 5.3x | 5.8x |
| Total assets | $1.6B | $1.8B | $1.9B | $2.3B | $2.4B |
| Total liabilities | $831M | $813M | $744M | $814M | $803M |
| Shareholders' equity | $813M | $947M | $1.2B | $1.5B | $1.6B |
| Net debt (β = net cash) | $88.3M | β$52.8M | β$222M | β$482M | β$423M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 8 / 9 | 6 / 9 |
| Accruals ratio | β4.1% | β6.9% | β4.0% |
| Altman Z'' | 6.90 | 7.97 | 8.81 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Stride LRN | $3.6B | 4.7% | 17.9% | 17.2% | 31.3% | 11.0x | 6 | |
| Covista CVSA | $4.7B | 9.3% | 19.6% | 20.1% | 17.0% | 18.7x | 8 | Compare β |
| Laureate Education LAUR | $5.5B | 8.6% | 25.3% | 15.5% | 28.6% | 17.7x | 8 | Compare β |
| Graham GHC | $5.3B | 2.5% | 4.8% | 5.6% | 3.1% | 18.3x | 5 | Compare β |
| Strategic Education STRA | $1.8B | 4.0% | 13.7% | 12.1% | 8.4% | 13.7x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $889M | $918M | $1.0B | $1.0B | $1.5B | $1.7B | $1.8B | $2.0B | $2.4B | $2.5B |
| Gross profit | $331M | $325M | $352M | $348M | $535M | $597M | $647M | $764M | $944M | $951M |
| Research and development | $12.5M | $9.2M | $9.5M | $9.7M | $3.7M | $7.5M | $15.5M | $16.7M | $16.6M | $22.0M |
| Operating income | $13.1M | $25.5M | $45.5M | $32.5M | $111M | $157M | $166M | $250M | $360M | $451M |
| Interest expense | $0.8M | $0.8M | $1.1M | $1.3M | $4.5M | $6.6M | $6.9M | $7.5M | $9.1M | $10.4M |
| Pretax income | $4.9M | $26.5M | $48.4M | $33.4M | $96.0M | $147M | $172M | $269M | $381M | $441M |
| Income tax | $5.4M | β$0.9M | $10.5M | $8.5M | $24.5M | $40.1M | $45.3M | $64.5M | $93.0M | $103M |
| Net income | $0.5M | $27.6M | $37.2M | $24.5M | $71.5M | $107M | $127M | $204M | $288M | $338M |
| Diluted EPS | $0.01 | $0.68 | $0.91 | $0.60 | $1.71 | $2.52 | $2.97 | $4.69 | $5.95 | $7.14 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $88.7M | $105M | $142M | $80.4M | $134M | $207M | $203M | $279M | $433M | $434M |
| Capital expenditure | $2.2M | $8.7M | $5.5M | $1.7M | $3.6M | $9.7M | $4.3M | $2.3M | $1.8M | $0.6M |
| Free cash flow | $86.6M | $96.7M | $136M | $78.7M | $131M | $197M | $199M | $277M | $431M | $433M |
| Depreciation and amortization | $74.3M | $75.3M | $71.4M | $72.1M | $90.1M | $97.9M | $110M | $110M | $115M | $127M |
| Stock-based compensation | $22.6M | $20.8M | $16.7M | $23.6M | $39.3M | $18.6M | $20.3M | $31.5M | $36.8M | $40.3M |
| Acquisitions | $9.1M | $7.3M | $13.1M | $168M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $27.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $189M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $27.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $189M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $231M | $231M | $283M | $212M | $386M | $389M | $523M | $692M | $985M | $958M |
| Total debt | β | β | β | β | $299M | $411M | $413M | $415M | $416M | $418M |
| Finance lease liabilities | $0.0M | $0.0M | $24.6M | $17.9M | $68.9M | $66.3M | $56.9M | $55.6M | $86.9M | $117M |
| Current assets | $474M | $454M | $530M | $501M | $858M | $951M | $1.1B | $1.2B | $1.6B | $1.7B |
| Current liabilities | $118M | $116M | $156M | $273M | $306M | $302M | $309M | $244M | $303M | $289M |
| Inventory | $30.5M | $25.9M | $29.9M | $28.3M | $39.7M | $36.0M | $36.7M | $36.7M | $37.6M | $38.2M |
| Property and equipment, net | $26.3M | $28.9M | $32.0M | $38.7M | $72.1M | $61.5M | $52.3M | $50.9M | $78.6M | $102M |
| Total assets | $735M | $742M | $820M | $1.1B | $1.6B | $1.6B | $1.8B | $1.9B | $2.3B | $2.4B |
| Total liabilities | $160M | $155M | $186M | $398M | $773M | $831M | $813M | $744M | $814M | $803M |
| Shareholders' equity | $574M | $587M | $633M | $675M | $805M | $813M | $947M | $1.2B | $1.5B | $1.6B |
| Margins | ||||||||||
| Gross margin | 37.3% | 35.4% | 34.7% | 33.4% | 34.8% | 35.4% | 35.2% | 37.4% | 39.2% | 37.8% |
| Operating margin | 1.5% | 2.8% | 4.5% | 3.1% | 7.2% | 9.3% | 9.0% | 12.2% | 15.0% | 17.9% |
| EBITDA margin | 9.8% | 11.0% | 11.5% | 10.1% | 13.1% | 15.1% | 15.0% | 17.6% | 19.7% | 22.9% |
| Net margin | 0.1% | 3.0% | 3.7% | 2.4% | 4.7% | 6.4% | 6.9% | 10.0% | 12.0% | 13.4% |
| FCF margin | 9.7% | 10.5% | 13.4% | 7.6% | 8.5% | 11.7% | 10.8% | 13.6% | 17.9% | 17.2% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | 13.5% | 13.6% | 20.5% | 27.9% | 31.3% |
| Return on capital employed | 2.1% | 4.1% | 7.1% | 4.4% | 10.7% | 12.0% | 11.9% | 16.0% | 19.6% | 21.8% |
| Return on equity | 0.1% | 4.8% | 6.1% | 3.8% | 9.7% | 13.3% | 14.4% | 19.2% | 21.7% | 21.7% |
| Return on assets | 0.1% | 3.7% | 4.8% | 2.6% | 5.4% | 6.7% | 7.5% | 11.1% | 13.7% | 14.3% |
| Growth | ||||||||||
| Revenue growth | 1.8% | 3.3% | 10.7% | 2.5% | 47.7% | 9.8% | 8.9% | 11.0% | 17.9% | 4.7% |
| Net income growth | β95.0% | 6,024.2% | 34.7% | β34.1% | 191.6% | 49.9% | 18.4% | 60.9% | 41.0% | 17.5% |
| EPS growth | β95.7% | 6,700.0% | 33.8% | β34.1% | 185.0% | 47.4% | 17.9% | 57.9% | 26.9% | 20.0% |
| FCF growth | β25.9% | 11.7% | 40.8% | β42.2% | 65.8% | 51.0% | 0.9% | 39.1% | 55.9% | 0.5% |
| Share count change | 1.7% | 2.9% | 0.8% | β0.7% | 3.0% | 1.4% | 0.7% | 1.9% | 11.2% | β2.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β0.1x | 0.4x | β0.2x | β0.6x | β1.0x | β0.7x |
| Debt / equity | β | β | β | β | 0.5x | 0.6x | 0.5x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 17.5x | 32.8x | 41.1x | 25.2x | 24.5x | 23.6x | 23.8x | 33.2x | 39.4x | 43.2x |
| Current ratio | 4.0x | 3.9x | 3.4x | 1.8x | 2.8x | 3.2x | 3.5x | 5.1x | 5.4x | 5.9x |
| Quick ratio | 3.8x | 3.7x | 3.2x | 1.7x | 2.7x | 3.0x | 3.3x | 5.0x | 5.3x | 5.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.2% | 1.0% | 0.5% | 0.2% | 0.2% | 0.6% | 0.2% | 0.1% | 0.1% | 0.0% |
| Stock comp / revenue | 2.5% | 2.3% | 1.6% | 2.3% | 2.6% | 1.1% | 1.1% | 1.5% | 1.5% | 1.6% |
| Payouts / FCF | 0.0% | 28.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 43.6% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | 6.0 | 7.0 | 8.0 | 8.0 | 6.0 |
| Altman Z'' | 6.9 | 7.1 | 7.0 | 3.5 | 4.1 | 4.7 | 5.3 | 6.9 | 8.0 | 8.8 |
| Accruals ratio | β12.0% | β10.5% | β13.4% | β5.9% | β4.7% | β6.2% | β4.5% | β4.1% | β6.9% | β4.0% |
Source: SEC EDGAR XBRL filings (CIK 0001157408). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.